NeuroImmunology
8.2K views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Scooped by Gilbert C FAURE
Scoop.it!

Multiple Sclerosis Research: Theory How Cells enter the Brain

Multiple Sclerosis Research: Theory How Cells enter the Brain | NeuroImmunology | Scoop.it
Through extensive studies in the multiple sclerosis model experimental autoimmune encephalomyelitis, we recently demonstrated that regional neural activation induces excess activation of the inflammation amplifier at ...
Gilbert C FAURE's insight:

a theory focusing on neural activation to explain cell migration into the brain and EAE

No comment yet.
Scooped by Gilbert C FAURE from Multiple sclerosis New Drugs Review
Scoop.it!

Imaging of immune cell behavior and function in multiple sclerosis and experimental autoimmune encephalomyelitis - Pesic - 2013 - Clinical and Experimental Neuroimmunology - Wiley Online Library

Imaging of immune cell behavior and function in multiple sclerosis ... Pesic 2013 Clinical and Exp Neuroimm http://t.co/1XiBjWYRVd

Via Krishan Maggon
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

BMC Neurology | Full text | Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance

BMC Neurology | Full text | Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance | NeuroImmunology | Scoop.it
While mental comorbidity is considered common in multiple sclerosis (MS), its impact is poorly defined; methods are needed to support studies of mental comorbidity.
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

A Closer Look at Multiple Sclerosis Treatments in 2014: BIIB, NVS, TEVA, SNY ... - DailyFinance

A Closer Look at Multiple Sclerosis Treatments in 2014: BIIB, NVS, TEVA, SNY ... - DailyFinance | NeuroImmunology | Scoop.it
A Closer Look at Multiple Sclerosis Treatments in 2014: BIIB, NVS, TEVA, SNY ...
No comment yet.
Scooped by Gilbert C FAURE from AUTOIMMUNITY
Scoop.it!

Another CNS phenotype of anti-... [J Neurol Neurosurg Psychiatry. 2013] - PubMed - NCBI

PubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
No comment yet.
Scooped by Gilbert C FAURE from AUTOIMMUNITY
Scoop.it!

Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study : The Lancet Neurology

Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. By - Nuria Gresa-Arribas PhD, Maarten J Titulaer MD, Abiguei Torrents BS, Esther Aguilar...
No comment yet.
Scooped by Gilbert C FAURE from AUTOIMMUNITY
Scoop.it!

Herpes Simplex Virus Encephalitis is a Trigger of... [Ann Neurol. 2013] - PubMed - NCBI

PubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
Gilbert C FAURE's curator insight, December 12, 2013 4:13 AM
of Brain Autoimmunity.
Scooped by Gilbert C FAURE from AUTOIMMUNITY
Scoop.it!

Dopamine Receptor Autoantibodies Correlate with Symptoms in Sydenham's Chorea

Dopamine Receptor Autoantibodies Correlate with Symptoms in Sydenham's Chorea | NeuroImmunology | Scoop.it
Cunningham Paper Links Autoimmunity with #Neuropsychiatric Symptoms. http://t.co/pqefELUu2B #autoimmunity #mentalhealth #dopamine
No comment yet.
Scooped by Gilbert C FAURE from AUTOIMMUNITY
Scoop.it!

Neuropsychiatric systemic lupus erythematosus: Pathophysiology and the future of treatment

Neuropsychiatric systemic lupus erythematosus: Pathophysiology and the future of treatment | NeuroImmunology | Scoop.it
Rheumatology Medical Article: Neuropsychiatric systemic lupus erythematosus: Pathophysiology and the future of treatment (RT @MDLinx: Neuropsychiatric systemic lupus erythematosus: Pathophysiology and the future of treatment: Inte...
No comment yet.
Scooped by Gilbert C FAURE from AUTOIMMUNITY
Scoop.it!

Mechanisms of autoimmunity in the central nervous system: Disturbance of natural autoimmunity, infectious agents, cell contribution and antibody signatures - Ortega-Hernandez - 2013 - Clinical and ...

Mechanisms of autoimmunity in the central nervous system: Disturbance of natural autoimmunity, infectious agents, cell contribution and antibody signatures - Ortega-Hernandez - 2013 - Clinical and ... | NeuroImmunology | Scoop.it
Mechanisms of autoimmunity in the central nervous system: 2013 Clinical and Experimental Neuroimmunology http://t.co/ssl82WabFE
No comment yet.
Scooped by Gilbert C FAURE from AUTOIMMUNITY
Scoop.it!

A case with anti-galactocerebroside antibody-posi... [Neurol Sci. 2012] - PubMed - NCBI

PubMed comprises more than 23 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
No comment yet.
Scooped by Gilbert C FAURE from AUTOIMMUNITY
Scoop.it!

Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica

Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica | NeuroImmunology | Scoop.it
RT @NatRevNeurol: Recombinant antigen-based assay improves detection of AQP4 antibodies in patients with NMO http://t.co/Nj6jUGuCz1 via @fe…
Gilbert C FAURE's insight:

Conclusions: Serological tests using recombinant AQP4 antigen are significantly more sensitive than tissue-based IIF for detecting AQP4-IgG. Testing should precede immunotherapy; if negative, later-drawn specimens should be tested. AQP4-IgG–seronegative NMO is less frequent than previously reported and is clinically similar to AQP4-IgG–seropositive NMO.

Scooped by Gilbert C FAURE from AUTOIMMUNITY
Scoop.it!

BMC Neurology | Abstract | Cognitive dysfunction associated with anti-glutamic acid decarboxylase autoimmunity: a case-control study

Glutamic acid decarboxylase (GAD) is the rate-limiting enzyme in the synthesis of gamma-aminobutyric acid (GABA).
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

A systematic review of randomized, double-blind, placebo-controlled trials examining the clinical efficacy of vitamin D in multiple sclerosis

A systematic review of randomized, double-blind, placebo-controlled trials examining the clinical efficacy of vitamin D in multiple sclerosis | NeuroImmunology | Scoop.it
A systematic review examining the clinical efficacy of vitamin D in multiple sclerosis http://t.co/1xPxE4LCJT
No comment yet.
Scooped by Gilbert C FAURE from Multiple sclerosis New Drugs Review
Scoop.it!

Daclizumab, an antibody, as possible alternative therapy to interferon beta in people with relapsing remitting multiple sclerosis | Cochrane Summaries

Daclizumab, an antibody, as possible alternative therapy to interferon beta in people with relapsing remitting multiple sclerosis | Cochrane Summaries | NeuroImmunology | Scoop.it
(Cochrane) No hay suficiente evidencia de la eficacia de daclizumab vs placebo en esclerosis múltiple http://t.co/LHI7YwFIzC #NoSinEvidencia

Via Krishan Maggon
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Why the FDA didn't approve Genzyme's multiple sclerosis drug, Lemtrada - Boston Business Journal (blog)

Why the FDA didn't approve Genzyme's multiple sclerosis drug, Lemtrada - Boston Business Journal (blog) | NeuroImmunology | Scoop.it
Why the FDA didn't approve Genzyme's multiple sclerosis drug, Lemtrada
Boston Business Journal (blog)
Genzyme's multiple sclerosis drug, Lemtrada, was rejected in the U.S.
No comment yet.
Scooped by Gilbert C FAURE
Scoop.it!

Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders -- Jacob et al. 84 (8): 922 -- Journal of Neurology, Neurosurgery & Psychiatry

Neuromyelitis Optica and NMO-spectrum disorders http://t.co/LzC0wXYDqr
#Neurology #Neuroimmunology #PODCAST here! http://t.co/blqIyWVdIf
No comment yet.
Scooped by Gilbert C FAURE from AUTOIMMUNITY
Scoop.it!

Management of disease modifying treatments in neurological autoimmune diseases of the central nervous system - Salmen - Clinical & Experimental Immunology - Wiley Online Library

Management of disease modifying treatments in neurological autoimmune diseases of the central nervous system - Salmen - Clinical & Experimental Immunology - Wiley Online Library | NeuroImmunology | Scoop.it
Immunology: Management of disease modifying treatments in neurological autoimmune diseases of the central nervous ... http://t.co/z0kvs3CmTY
No comment yet.
Scooped by Gilbert C FAURE from AUTOIMMUNITY
Scoop.it!

Autoimmunity, seizures, and status epilepticus - Davis - 2013 - Epilepsia - Wiley Online Library

Autoimmunity, seizures, and status epilepticus - Davis - 2013 - Epilepsia - Wiley Online Library | NeuroImmunology | Scoop.it
Autoimmunity, seizures, and status epilepticus. Epilepsia 2013 http://t.co/FcFSrcuJ84
Gilbert C FAURE's curator insight, December 18, 2013 6:07 AM

already posted in september as pubmed reference

see also neurology in this topic

http://www.scoop.it/t/autoimmunity?q=neurology

 

Scooped by Gilbert C FAURE from AUTOIMMUNITY
Scoop.it!

Anti-JC virus (JCV) antibody prevalence in the JCV Epidemiology in MS (JEMS) trial - Bozic - 2013 - European Journal of Neurology - Wiley Online Library

Anti-JC virus (JCV) antibody prevalence in the JCV Epidemiology in MS (JEMS) trial - Bozic - 2013 - European Journal of Neurology - Wiley Online Library | NeuroImmunology | Scoop.it
RT @DrJesusPorta: Anti-JC virus (JCV) antibody prevalence in the JCV Epidemiology in MS (JEMS) trial - Bozic -... http://t.co/xpBG0qgHZh
No comment yet.
Scooped by Gilbert C FAURE from AUTOIMMUNITY
Scoop.it!

Basis for fluctuations in lymphocyte counts in fingolimod-treated patients with multiple sclerosis

Basis for fluctuations in lymphocyte counts in fingolimod-treated patients with multiple sclerosis | NeuroImmunology | Scoop.it
RT @GreenJournal: Basis for fluctuations in lymphocyte counts in fingolimod-treated patients with MS
http://t.co/QHzAbHjHWv #Neurology htt…
No comment yet.
Scooped by Gilbert C FAURE from AUTOIMMUNITY
Scoop.it!

Frontiers | Programming of neuroendocrine self in the thymus and its defect in the development of neuroendocrine autoimmunity | Frontiers in Neuroendocrine Science

For centuries after its first description by Galen, the thymus was considered as only a vestigial endocrine organ until the discovery in 1961 by Jacques FAP Miller of its essential role in the development of T (thymo-dependent) lymphocytes.
No comment yet.
Scooped by Gilbert C FAURE from AUTOIMMUNITY
Scoop.it!

Mast cells, glia and neuroinflammation: partners in crime? - Skaper - Immunology - Wiley Online Library

Mast cells, glia and neuroinflammation: partners in crime? - Skaper - Immunology - Wiley Online Library | NeuroImmunology | Scoop.it
RT @BSIHQ: Partners in crime? Mast cells, glia and neuroinflammation. Free article from #immunology http://t.co/Loe3UyyAeX http://t.co/JhUu…;
No comment yet.
Scooped by Gilbert C FAURE from AUTOIMMUNITY
Scoop.it!

GABAB receptor autoantibody frequency in service serologic evaluation

GABAB receptor autoantibody frequency in service serologic evaluation | NeuroImmunology | Scoop.it
RT @GreenJournal: GABAB receptor autoantibody frequency in service serologic evaluation
http://t.co/Wyd9qA1OEp #Neurology http://t.co/GPf…;
Gilbert C FAURE's insight:

Conclusion: GABABR autoantibody is a marker of an uncommon but treatable paraneoplastic neurologic disorder, usually occurring in the setting of limbic encephalitis and SCLC.

No comment yet.
Scooped by Gilbert C FAURE from AUTOIMMUNITY
Scoop.it!

Paraneoplastic neurological syndromes - Leypoldt - Clinical & Experimental Immunology - Wiley Online Library

Paraneoplastic neurological syndromes - Leypoldt - Clinical & Experimental Immunology - Wiley Online Library | NeuroImmunology | Scoop.it
Paraneoplastic neurological syndromes Leypoldt Clinical & Experimental Immunology Wiley Online Library http://t.co/C9NgBxJuBn
Gilbert C FAURE's insight:

Paraneoplastic neurological syndromes are immune-mediated erroneous attacks on the central or peripheral nervous systems, or both, directed originally against the tumour itself. They have been known for more than 40 years, but recently the discovery of new subgroups of paraneoplastic encephalitis syndromes with a remarkably good response to immune therapy has ignited new clinical and scientific interest. Knowledge of these subgroups and their associated autoantibodies is important in therapeutic decision-making. However, the abundance of new autoantibodies and syndromes can be confusing. This review paper summarizes current knowledge and new developments in the field of paraneoplastic neurological syndromes, their classification, pathophysiology and treatment.

No comment yet.